Cáncer colorrectalFase 2NCT06617858
Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment
AMB-05X
39 estudios de fase 2 reclutando ahora mismo, los actualizados más recientemente primero.
Abrir la página de fase 2 · una lista solo de esos estudios
Triangle is made by Triangle Health, Inc.
Colorrectal y anal39 estudios
Cáncer colorrectalFase 2NCT06617858
AMB-05X
Cáncer colorrectalFase 2NCT07235293
DSP107 + Atezolizumab, Fruquintinib
Colorectal Carcinoma Metastatic in the LiverFase 2NCT06555133
yttrium-90 radioembolization
Cáncer colorrectalFase 2NCT06728072
Standard of Care Chemotherapy + Metronidazole, ciprofloxacin, aspirin
Early Rectal CancerFase 2NCT07735624
Botensilimab, Balstilimab
Anal CancerFase 2NCT07425054
HPV ctDNA Response based radiation, Chemotherapy, Retifanlimab
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)Fase 2NCT06589440
SR-8541A
Colorectal Cancer MetastaticFase 2NCT07550088Artículos
Balstilimab (BAL), Botensilimab (BOT), agenT-797
Small Bowel AdenocarcinomaFase 2NCT06835387
Nanoliposomal irinotecan, Oxaliplatin, 5 fluorouracil, Leucovorin
Cáncer colorrectalFase 2NCT06948448
ONO-4578, Opdivo®, Oxaliplatin, 5-Fluorouracil
Appendiceal Mucinous NeoplasmFase 2NCT07693452
Metformin
Rectal CancerFase 2NCT04643366
Chemotherapy, Radiation Therapy
Rectal AdenocarcinomaFase 2NCT06780787
Balstilimab, Biospecimen Collection, Botensilimab, Capecitabine
Microsatellite Stable Rectal CarcinomaFase 2NCT06843434
Balstilimab, Botensilimab
Colon CancerFase 2NCT05239546
Dostarlimab